The UK and the EU are at a stand-off over vaccines as the EU demands the diversion of vaccines produced in the UK to make up for shortfalls in the European Union.
German MEP Peter Liese, a member of the European Parliament’s health committee, said that the UK had “better think twice”, telling Euronews:
💥German MEP Peter Liese, who sits on the Health Committee, tells me
European Union citizens will not be treated as second class
If AstraZeneca don’t change course, it will face consequences and so will UK “better think twice” – including blocking Pfizer exports pic.twitter.com/xaBLrisOH5
— Darren McCaffrey (@DarrenEuronews) January 27, 2021
The demand from the EU follows a war of words between the two sides, including threats of lawsuits.
On Wednesday, the EU said that Astra “had pulled out of the scheduled call, in what would be an unprecedented snub of 27 governments”.
The drug maker denied that account.
According to Bloomberg:
“EU countries are desperate to speed up vaccinations after a sluggish start that’s left the bloc lagging far behind the U.S. and the U.K. The EU has administered just 2.2 doses per 100 people, versus 7.5 doses in the U.S., 11 doses in the U.K. and almost 45 doses in Israel. Astra’s vaccine isn’t due to be authorized for use in the bloc until Friday at the earliest.”
The public fight has epitomised the bloc’s failure to put its mass vaccination campaign on the right track added the US news outlet here.